SEC
CNMD icon

Seven Eight Capital’s CONMED CNMD Stock Holding History

Seven Eight Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,593
Closed -$474K – 139
2024
Q3 		$474K Buy
+6,593
New +$465K 0.04% 571
2023
Q2 		– Sell
-2,441
Closed -$254K – 519
2023
Q1 		$254K Buy
+2,441
New +$236K 0.05% 363
2022
Q4 		– Sell
-2,730
Closed -$219K – 447
2022
Q3 		$219K Buy
+2,730
New +$258K 0.04% 433
2020
Q2 		– Sell
-4,500
Closed -$258K – 364
2020
Q1 		$258K Sell
4,500
-9,409
-68% -$868K 0.07% 346
2019
Q4 		$1.55M Buy
13,909
+8,409
+153% +$896K 0.08% 367
2019
Q3 		$529K Buy
+5,500
New +$516K 0.03% 510

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Seven Eight Capital's CNMD Position: Q4 2024 in Review

Seven Eight Capital sold out of CONMED (CNMD) in Q4 2024, closing a stake of 6,593 shares — an estimated $474K sold.

Seven Eight Capital first reported a position in CNMD in Q3 2019 and held it in 6 quarters. The position peaked at $1.55M in Q4 2019. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Seven Eight Capital reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 6,593 CONMED shares in Q4 2024, an estimated $474K.
  • Seven Eight Capital first reported a position in CONMED in Q3 2019 and held it in 6 quarters.
  • Seven Eight Capital's CONMED position peaked at $1.55M in Q4 2019.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.